EWTX
Edgewise Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$45.32
−3.45%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.55
- Revenue estimate
- $129.2M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.53
- EPS estimate
- -$0.47
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -4.1%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $51
- PT range
- $36 – $60
- Analysts
- 5
4 Buy1 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.47 | -$0.53 | Miss -13.32% | — |
| May 7, 2026 | -$0.50 | -$0.46 | Beat 8.00% | — |
| Feb 26, 2026 | -$0.43 | -$0.49 | Miss -13.46% | — |
| Nov 6, 2025 | -$0.40 | -$0.39 | Beat 2.50% | — |
| Aug 7, 2025 | -$0.42 | -$0.34 | Beat 19.05% | — |
| May 8, 2025 | -$0.45 | -$0.43 | Beat 4.44% | — |
| Mar 3, 2025 | -$0.39 | -$0.42 | Miss -7.69% | — |
| Nov 7, 2024 | -$0.37 | -$0.36 | Beat 2.70% | — |
| Aug 8, 2024 | -$0.36 | -$0.34 | Beat 5.56% | — |
| May 9, 2024 | -$0.39 | -$0.33 | Beat 15.38% | — |
| Feb 22, 2024 | -$0.44 | -$0.47 | Miss -6.82% | $2.3M |
| Nov 9, 2023 | -$0.40 | -$0.41 | Miss -2.50% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026